Xiayuxue Decoction Plays an Antidevelopment Role in Hepatocellular Carcinoma through Intestinal-Hepatic Axis
Digestion · 2025
DOI: 10.1159/000543834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, 2025. Verfasst von Xiaoyan Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chinese Pharmacy, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
In recent years, the effect of “intestinal-hepatic axis” in tumorigenesis of hepatocellular carcinoma (HCC) has been paid more and more attention, and the imbalance of gut microbiota is closely related to the pathogenesis of HCC. The Xiayuxue decoction (XYXD) has inhibitory effect on hepatic fibrosis, but the effect of XYXD on HCC is not clear.
Methods
We induced HCC mouse model by diethylnitrosamine and CCL4. HCC mice were treated with XYXD gavage. Hematoxylin-eosin staining was used to detect the pathological changes of liver tissue in mice. Immunohistochemistry was used to detect the level of Ki-67 in liver tumor and ZO-1 in colon tissue. The level of inflammatory factors in plasma, liver, and colon tissue of mice was detected by ELISA. The changes of macrophages and neutrophils in colorectal tissues of mice were counted by immunofluorescence. 16S sequencing was used to analyze the effect of XYXD treatment on gut microbiota of HCC mice.
Results
Our study found that XYXD could inhibit the progress of HCC. XYXD upregulated the expression levels of ZO-1, occludin, and claudin in colon tissue to repair intestinal mucosal barrier. XYXD could alleviate the infiltration of intestinal immune cells in HCC mice by inhibiting the data of macrophages and neutrophils in colon tissue and downregulating SIgA level. XYXD also regulated the composition of intestinal microorganisms and improved the diversity of gut microbiota, thus affecting the progress of HCC.
Conclusion
XYXD inhibits the progress of HCC by influencing gut microbiota to regulate intestinal and liver inflammation and intestinal immune response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chinese Pharmacy, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
- College of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
- College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China.
Zitieren
APA
Zeng, X., Zhou, T., Pei, L., Chen, Y., Wang, X., Fang, H., Zeng, X., & Tian, X. (2025). Xiayuxue Decoction Plays an Antidevelopment Role in Hepatocellular Carcinoma through Intestinal-Hepatic Axis. Digestion. https://doi.org/10.1159/000543834
Vancouver
Zeng X, Zhou T, Pei L, Chen Y, Wang X, Fang H, et al. Xiayuxue Decoction Plays an Antidevelopment Role in Hepatocellular Carcinoma through Intestinal-Hepatic Axis. Digestion. 2025. doi:10.1159/000543834
BibTeX
@article{Zeng2025,
author = {Zeng, Xiaoyan and Zhou, Ting and Pei, Liyuan and Chen, Ya and Wang, Xuejing and Fang, Hongyu and Zeng, Xiaoyan and Tian, Xuefei},
title = {Xiayuxue Decoction Plays an Antidevelopment Role in Hepatocellular Carcinoma through Intestinal-Hepatic Axis},
journal = {Digestion},
year = {2025},
doi = {10.1159/000543834}
}
EUVIMED